Circulating tumour cell analysis to predict efficacy of Eribulin for metastatic breast cancer patients

被引：0
|
作者：
Horimoto, Yoshiya [1 ]
Murakami, Fumi [1 ]
Saito, Mitsue [1 ]
机构：
[1] Juntendo Univ, Sch Med, Dept Breast Oncol, Tokyo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-2072
引用
收藏
页码：664 / 664
页数：1
相关论文
共 50 条
  • [41] Safety of eribulin in Korean patients with metastatic breast cancer.
    Park, Yeon Hee
    Im, Young-Hyuck
    Lee, Keun-Seok
    Park, In Hae
    Sohn, Joohyuk
    Lee, Soohyeon
    Kim, Tae Yong
    Im, Seock-Ah
    Kim, Jee Hyun
    Kim, Se Hyun
    Lee, Soo Jung
    Koh, Su-Jin
    Lee, Ki Hyeong
    Choi, Yoon Ji
    Cho, Eun Kyung
    Lee, Suee
    Kang, Seok Yun
    Seo, Jae Hong
    Kim, Sung-Bae
    Jung, Kyung Hae
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] Eribulin Suppresses New Metastases in Patients With Metastatic Breast Cancer
    Fujii, Takaaki
    Tokuda, Shoko
    Nakazawa, Yuko
    Kurozumi, Sasagu
    Obayashi, Sayaka
    Yajima, Reina
    Shirabe, Ken
    IN VIVO, 2020, 34 (02): : 917 - 921
  • [43] Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients
    B Weigelt
    A J Bosma
    A A M Hart
    S Rodenhuis
    L J van't Veer
    British Journal of Cancer, 2003, 88 : 1091 - 1094
  • [44] Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients
    Weigelt, B
    Bosma, AJ
    Hart, AAM
    Rodenhuis, S
    van't Veer, LJ
    BRITISH JOURNAL OF CANCER, 2003, 88 (07) : 1091 - 1094
  • [45] Whole exome sequencing of circulating and disseminated tumour cells in patients with metastatic breast cancer
    Peeters, Dieter J. E.
    De Beeck, Ken Op
    Brouwer, Anja
    Vandeweyer, Geert
    Pauwels, Patrick
    Peeters, Marc
    Vermeulen, Peter B.
    van Dam, Peter A.
    Van Laere, Steven J.
    Van Camp, Guy
    Dirix, Luc Y.
    CANCER RESEARCH, 2015, 75
  • [46] Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients
    Krawczyk, Natalia
    Neubacher, Melissa
    Meier-Stiegen, Franziska
    Neubauer, Hans
    Niederacher, Dieter
    Ruckhaeberle, Eugen
    Mohrmann, Svjetlana
    Hoffmann, Juergen
    Kaleta, Thomas
    Banys-Paluchowski, Malgorzata
    Reinecke, Petra
    Esposito, Irene
    Janni, Wolfgang
    Fehm, Tanja
    BMC CANCER, 2019, 19 (01)
  • [47] The detection of circulating tumour cells in blood of metastatic breast cancer patients is of prognostic relevance
    O. Zach
    B. Zellhofer
    M. Födermayr
    H. Kasparu
    M. Girschikofsky
    W. Hehenwarter
    H. Hauser
    R. Függer
    W. Havlicek
    D. Lutz
    memo - Magazine of European Medical Oncology, 2008, 1 (4)
  • [48] Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer
    Peeters, D. J. E.
    Van den Eynden, G. G.
    van Dam, P-J
    Prove, A.
    Benoy, I. H.
    van Dam, P. A.
    Vermeulen, P. B.
    Pauwels, P.
    Peeters, M.
    Van Laere, S. J.
    Dirix, L. Y.
    BRITISH JOURNAL OF CANCER, 2011, 104 (09) : 1472 - 1477
  • [49] Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patients
    Muendlein, Axel
    Geiger, Kathrin
    Gaenger, Stella
    Dechow, Tobias
    Nonnenbroich, Christoph
    Leiherer, Andreas
    Drexel, Heinz
    Gaumann, Andreas
    Jagla, Wolfgang
    Winder, Thomas
    Mayer, Frank
    Decker, Thomas
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [50] Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients
    Natalia Krawczyk
    Melissa Neubacher
    Franziska Meier-Stiegen
    Hans Neubauer
    Dieter Niederacher
    Eugen Ruckhäberle
    Svjetlana Mohrmann
    Jürgen Hoffmann
    Thomas Kaleta
    Malgorzata Banys-Paluchowski
    Petra Reinecke
    Irene Esposito
    Wolfgang Janni
    Tanja Fehm
    BMC Cancer, 19
12345